Roche

Earendil Labs announced a research collaboration with Genentech (Roche Group) to discover bispecific antibodies in oncology using Earendil's AI-driven biologics platform; Earendil reports $55 million upfront and potential value above $1.5 billion.

Partners: Earendil Labs

Recursion reports that a joint Recursion-Genentech team identified and validated a first target from an AI-driven neuroscience map, now advancing into a joint small-molecule early discovery program.

Partners: Recursion

Vendor blog recapping a Roche talk: ThoughtSpot says Roche scaled to 500 active users of ThoughtSpot's Spotter AI analytics agent within a year, and has 40,000+ ThoughtSpot users overall.

Partners: ThoughtSpot

Vendor case study: Roche's patent organization built Lex, an agentic AI interface in Dataiku that orchestrates RAG, full-text and deep search for patent attorneys.

Partners: Dataiku

Roche agreed to acquire PathAI, whose AI pathology platform will join Roche Diagnostics and support companion diagnostics and biopharma clinical-trial and translational services; closing expected H2 2026.

Partners: PathAI

Roche added 2,176 NVIDIA Blackwell GPUs on premises in the US and Europe, bringing its combined on-premise and cloud footprint to more than 3,500 GPUs, as the next phase of an NVIDIA collaboration begun in 2023.

Partners: NVIDIA

Roche and Genentech (gRED) run a Lab-in-the-Loop approach that connects biology and chemistry experiments with Roche's AI models, now enhanced with NVIDIA BioNeMo.

Partners: NVIDIA

Roche says digital twins of production lines, powered by NVIDIA Omniverse libraries, let engineers optimize processes and factory designs.

Partners: NVIDIA